Generic Name and Formulations:
Vancomycin HCl 3.75g, 7.5g, 15g; pwd for oral soln after reconstitution; grape-flavored.
Indications for FIRVANQ:
C. difficile-associated diarrhea. Enterocolitis due to S. aureus.
Limitations Of use:
Oral vancomycin HCl not effective for treatment of other types of infections.
C. difficile-associated diarrhea: 125mg 4 times a day for 10 days. Enterocolitis: 500mg–2g per day in 3–4 divided doses for 7–10 days.
40mg/kg per day in 3–4 divided doses for 7–10 days; max 2g/day.
Renal insufficiency and/or colitis. Inflammatory bowel disorders. Underlying hearing loss. Monitor hearing, blood, renal function. Consider monitoring vancomycin serum concentrations. Not for endophthalmitis prophylaxis. Elderly. Pregnancy. Nursing mothers.
Monitor with aminoglycosides, other neurotoxic, nephrotoxic, or ototoxic drugs.
Nausea, abdominal pain, hypokalemia; ototoxicity, nephrotoxicity, superinfection.
Kit—1 (w. diluent)